2018 American Transplant Congress
Intervention for Splenorenal Shunt May Decrease the Incidence of Post-Liver Transplant Acute Kidney Injury
Dept. of Surgery, University of Virginia Health System, Charlottesville, VA.
Background: Splenorenal shunt (SRS) is a type of portosystemic shunt that develops frequently in the setting of chronic portal hypertension and cirrhosis. It remains controversial…2018 American Transplant Congress
Comparison of Pure Laparoscopic vs Open Living Donor Right Hepatectomy
Department of Surgery, Seoul National University Bundang Hospital, Gyeonggi-do, Korea.
Background With the development of laparoscopic skills, its application has expanded in living donor liver transplantation. However, due to technical difficulties, pure laparoscopic donor hepatectomy…2018 American Transplant Congress
Impact of Donor Age on Outcomes after Living Donor Liver Transplantation
Background: Liver transplantation (LT) is a curative treatment for decompensated cirrhosis and fulminant hepatitis. Although not a few patients received LT with marginal donor livers…2018 American Transplant Congress
Preventing Recurrence of Incisional Hernia after Liver Transplantation
Transplant Surgery, Indiana University, Indianapolis, IN.
Background: Incisional hernia is a well-known complication of orthotopic liver transplantation (OLT). Although factors that affect incidence of hernia after OLT have been described, recurrence…2018 American Transplant Congress
A High Abdominal Aortic Calcification Score by Dual X-Ray Absorptiometry (DXA) is Associated with Cardiovascular Events after Kidney Transplantation
Introduction: It is unknown whether aortic calcification is associated with increased risk for cardiovascular events in renal transplant recipients. Therefore, this study focused on the…2018 American Transplant Congress
Effect of Belatacept on Late Acute Rejection Episodes and Graft Loss in Young Adults between the Ages of 18-24 Years: Post-Hoc Analysis of BENEFIT Study
Nephrology, Children National Health System, Washington, DC.
Background: Recent data suggests higher incidence of late acute rejection (LAR) in young adults (18-24 years of age) causing graft loss just like adolescents due…2018 American Transplant Congress
mTORC2 Deficiency in CD11c+ dendritic Cells Promotes Acute Kidney Injury
Introduction: The role of the mammalian/mechanistic target of rapamycin (mTOR) in the pathophysiology of renal ischemia-reperfusion injury (IRI) is poorly characterized; furthermore, the influence of…2018 American Transplant Congress
Five-Year Outcomes after Randomized Treatment by Rituximab in Early Acute Antibody-Mediated Rejection in Renal Transplantation: Long Term Outcomes of the RITUX ERAH Study
Background The place of rituximab in the treatment of acute antibody-mediated rejection (ABMR) is still controversial. The French multicenter double-blind, placebo-controlled RITUX ERAH study included…2018 American Transplant Congress
The ATHENA Study: 12 Months Safety and Efficacy Data from Everolimus Combined with Tacrolimus or Cyclosporine Compared to a Standard Tacrolimus-Mycophenolate Regimen in De Novo Kidney Transplant Patients
1Athena Study Group, Germany; 2Athena Study Group, France; 3Novartis, Pharma, Germany.
The ATHENA study was set up to compare efficacy and safety of everolimus [EVR] combined with tacrolimus [TAC] or cyclosporine A [CyA] vs. a mycophenolic…2018 American Transplant Congress
Factors Related to Suboptimal Recovery of Renal Function after Living Donor Nephrectomy
Japanease Red Cross Kumamoto Hospital, Kidney Center, Kumamoto, Japan.
Introduction:Renal function of the living donor usually recovers to 60~70 percent of baseline function by compensatory hypertrophy mechanism. However, the degree of this compensatory hypertrophy…
- « Previous Page
- 1
- …
- 51
- 52
- 53
- 54
- 55
- …
- 211
- Next Page »